Clinical Trials on Intermediate or High-risk Bladder Cancer
Total 218 results
-
PhotocureKarl StorzCompletedIntermediate or High-risk Bladder Cancer
-
Azienda Socio Sanitaria Territoriale degli Spedali...TakedaUnknownIntermediate Risk Prostate Cancer | High Risk Prostate CancerItaly
-
Prisma Health-UpstateRecruiting
-
Memorial Sloan Kettering Cancer CenterCompletedBladder Cancer | High Risk SuperficialUnited States
-
University of Texas Southwestern Medical CenterCompletedHigh-Risk Cancer
-
UNICANCERRecruitingPatients With High-risk MIBCFrance
-
Henry Ford Health SystemAmerican Cancer Society, Inc.WithdrawnLow or Intermediate Risk Prostate CancerUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingHigh Risk Acute Myeloid Leukemia | Intermediate Risk Acute Myeloid LeukemiaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingPremenopausal Breast Cancer | Hormone-receptor-positive Breast Cancer | Breast Cancer Patients at Intermediate to High Risk | Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or TorimefenChina
-
University Hospital, GrenobleRecruitingRadiation Therapy, Breast Cancer, Sequential Partial Breast Irradiation | Intermediate and High-risk Luminal and Triple Negative Breast CancerFrance
-
Brigham and Women's HospitalCompletedKnown CAD, or Intermediate-high Pretest Likelihood for CADUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
Memorial Sloan Kettering Cancer CenterCompletedCancer Survivors | Statin Use Among High Risk SurvivorsUnited States
-
Institut CurieCompletedMetastatic and/or High Risk Solid Tumor of ChildrenFrance
-
Archivel Farma S.L.Fundació Institut Germans Trias i PujolCompletedHigh-Risk Non-Muscle-Invasive Bladder CancerSpain
-
RemeGen Co., Ltd.Not yet recruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Cairo UniversityUnknownUrothelial Carcinoma Bladder | High-Risk CancerEgypt
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Norway, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Co... and more
-
European Institute of OncologyTerminated
-
Yonsei UniversityNot yet recruitingHealthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular DiseaseKorea, Republic of
-
Genesis Research LLCRecruitingProstate Cancer | Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance RegimenUnited States
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
Meshalkin Research Institute of Pathology of CirculationUnknownPulmonary Embolism | Intermediate-high Risk | Combination of Oral Anticoagulation Therapy and SildenafilRussian Federation
-
University of British ColumbiaWithdrawnBladder Cancer | High-Risk Cancer | Durvalumab | Non-muscle Invasive | TremelimumabCanada
-
Hospices Civils de LyonNot yet recruitingHigh-risk Thoracic Cancer SurgeryFrance
-
RWTH Aachen UniversityTerminated
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
NHS LothianNot yet recruitingLow Risk Prostate Cancer | Intermediate Risk Prostate Cancer | Localized Prostate Cancer
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
Centre Francois BaclesseTerminatedProstate Cancer With Intermediate RiskFrance
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaActive, not recruitingLow or Intermediate Risk Prostate CancerCanada
-
Tianjin Medical University Second HospitalRecruitingHigh-Risk Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Tianjin Medical University Second HospitalRecruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | High-RiskChina
-
Tianjin Medical University Second HospitalRecruitingHer2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
University of OxfordVaccitech (UK) LimitedUnknownCastration-resistant Prostate Cancer | Intermediate Risk Prostate CancerUnited Kingdom
-
University Health Network, TorontoClinical Laserthermia Systems ABUnknownProstate Cancer | Low and Intermediate Risk Prostate CancerCanada
-
University of Roma La SapienzaNot yet recruitingNon-muscle-invasive Bladder Cancer | Non-Muscle Invasive Bladder Urothelial Carcinoma | High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
-
National Cancer Institute (NCI)CompletedRisk Reduction Behavior | High Risk for Breast CancerUnited States
-
Fox Chase Cancer CenterCompletedMuscle Invasive Bladder Cancer | High Risk Urothelial Carcinoma of the Upper Urinary TractsUnited States
-
University Health Network, TorontoActive, not recruitingMutation | Hereditary Cancer Syndrome | High-Risk | Germline MutationCanada
-
EBG MedAustron GmbHRecruitingLow Risk Prostate Cancer | Intermediate Risk Prostate CancerAustria
-
Northwell HealthTerminatedHigh Risk MC4R Genotype | Low Risk MC4R Genotype | One Week or Less Antipsychotic Lifetime ExposureUnited States
-
Centre Francois BaclesseFrench cancer Institute INCaRecruitingThyroid Cancer | Intermediate RiskFrance
-
AstraZenecaCompletedPostoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) PatientsRussian Federation
-
Israeli Medical AssociationRecruitingHigh-Risk Cancer | Philadelphia-Negative ALLIsrael
-
University Medical Center GroningenTerminatedHigh-Risk Breast CancerNetherlands